Big Pharma Stock Investors Beware: Another $250 Billion Patent Cliff Is Coming
Several big pharma companies are about to lose patent exclusivity for blockbuster drugs. Should investors be worried?
Several big pharma companies are about to lose patent exclusivity for blockbuster drugs. Should investors be worried?
Does stock market volatility have you feeling low? Dividends can help make it better.
Find out which home improvement retailer investors should prefer for the long haul.
Both of these stocks are growing earnings by double-digit percentages, yet struggle to gain respect from investors.
U.S. company General Electric should be fined if it does not create as many jobs at Alstom as agreed when it purchased its energy subsidiary in 2015, a French government spokesman said on Sunday. GE had committed to create 1,000 net new jobs by the end of this year when it bought Alstom's energy business in 2015, but had created only 323 by the end of April, the Finance Ministry said last week. GE Chief Executive John Flannery informed French Finance Minister Bruno Le Maire this week that the target was now "out of reach" because of difficult market conditions.
One top marijuana stock. One legendary investor. And four tough criteria to meet.
It's the only stock in the S&P 500 that meets all these criteria.